T herapeutic revascularization of ischemic tissues based on cell therapy approaches has been a topic of significant interest during the past decade. Most attempts to induce tissue revascularization have been based on homogeneous monocell therapies. [1] [2] [3] [4] [5] [6] Recently, the concept of coinjecting mixtures of 2 complementary vasculogenic cell types, exemplified by the combination of endothelial (EC) and stromal/mural cells, has received growing attention for engineering augmented vascular networks. 7-9 This concept is based on the idea that the presence of mural cells or mural progenitors in the therapeutic mixture will enhance EC survival and promote stabilization of developing neovessels.
networks. 21, 22 In vivo coimplantation of EC and ASC results in the development of multilayered donor cell-derived vascular networks, where EC form the inner layer of the vessels and ASC form the outer layer. These vessels develop in several days after injection and stably integrate into host vasculature. 9, 23, 24 The formation of stable vessels is a complex process requiring finely orchestrated interactions between 2 cell types, EC and mural/pericyte cells, and the surrounding environment. Previously, to facilitate mechanistic analysis of EC-ASC interactions, we introduced an in vitro model of cocultivation of human EC and ASC in a system containing serum but no additional exogenous cytokines or extracellular matrix. 25 Using this model, we have shown that ASC have a superior potential to stimulate EC morphogenesis into stable cord structures arranged in branching networks. This process of morphogenesis is dependent on cell communication involving vascular endothelial growth factor, hepatocyte growth factor, plateletderived growth factor BB (PDGF-BB) pathways, matrix metalloproteinase activity, and involves extracellular matrix protein production by both cell types, and upregulation of platelet endothelial cell adhesion molecule 1 by EC as a sign of maturation. 25 In addition, vascular network formation (VNF) is associated with induction of α-smooth muscle actin (αSMA) expression in ASC, which is initiated in regions of contact between ASC and EC. Recently, these observations were supported by several other studies using similar models. 26, 27 To extend our understanding of the mechanisms governing the interactions between EC and ASC further, specifically the ones that prompt ASC transition from a progenitor phenotype toward smooth muscle lineage, we conducted the present study using an in vitro model of EC-ASC cocultivation. 25 
Methods
Detailed methodology is provided in the Online Data Supplement. Procedures for collecting umbilical cord and adipose tissue were approved by the Indiana University School of Medicine Institutional Review Board. Human ASC and cord blood-derived EC (CBD-EC) were isolated as previously described. 21, 28 Human cardiac microvascular EC, human retinal EC, and aortic SMC were purchased from Lonza.
Coculture of EC and ASC
The EC-ASC coculture model was established as previously described. 25 6×10 4 ASC/cm 2 and 5×10 3 CBD-EC/cm 2 were premixed, plated, and incubated in endothelial basal media EBM-2 with 5% FBS or 1% BSA. To evaluate VNF by SVF of adipose tissue, freshly isolated SVF was plated at 120×10 4 cells/cm 2 alone or with 10 4 CBD-EC/cm 2 .
To assess the role of factors in EC-ASC interactions, cocultures were incubated in EBM-2/5% FBS with one of the following neutralizing IgG or matching control IgG: activin A IgG, transforming growth factor-β1 (TGF β1 ) IgG, TGF β pan-specific IgG, or with 1 to 10 µmol/L ALK4/5/7 inhibitor (Inh_II), or 10 µmol/L SB431542, or dimethyl sulfoxide. Cocultures were incubated for 6 days with a media change at day 3.
To evaluate the necessity of direct EC-ASC contact for EC modulation of activin A production by ASC, ASC were cultured either alone or with EC on Transwell inserts with 0.4-µm-diameter pore size of the mesh. For direct contact, EC and ASC were cultured on the same side of insert, whereas to achieve close proximity without direct contact the 2 cell populations were seeded on opposite faces of the membrane. Cells were incubated for 9 days with media exchange every 3 days. Media collected at day 9 were evaluated.
Experiments Assessing the ASC Acquisition of SMC Properties
To assess ASC ability to differentiate along an SMC path, confluent ASC were incubated in EBM-2/5% FBS alone or supplemented with 10 ng/mL TGF β or 25 ng/mL activin A; 24-hour conditioned media (CM) from ASC or EC-ASC cultures collected daily for 7 days after culture initiation; 48-hour CM from EC-ASC coculture collected at day 10. In similar experiments designed to address the effects of activin A modulation, 48-hour CM were collected at day 8 from EC-ASC cocultures established with intact ASC, ASC transfected with scrambled RNA (scRNA), or siRNA to inhibin B A (monomer of activin A). To test the relative contribution of activin A or TGF β1 to EC-ASC CM activity, the medium was admixed with either (1) neutralizing antiactivin A or anti-TGF β1 IgG, or matching control mouse or chicken IgG or (2) 1 µmol/L ALK4/5/7 inhibitor (Inh_II) or dimethyl sulfoxide. ASC were exposed to treatments for 6 days, with media change on day 3.
Cell Suspension Separation by Flow Cytometry Technique
To separate EC-ASC cocultures into individual cell types, cells were harvested at day 6, incubated with CD140b-PE (ASC marker) and CD31-APC (EC marker) IgG, and separated using Aria Cell Sorter (BD).
Analysis of Inhibin B A Expression in Subcutaneously Implanted EC-ASC Cell Mixtures
CBD-EC and ASC were premixed (1:1), combined with Matrigel to a final concentration of 3×10 7 cell/mL, and subcutaneously implanted on the back of NOD/SCID/IL2Rγ mice. Plugs, harvested at days 1 and 7, were evaluated for mRNA expression by quantitative polymerase chain reaction or for human vessels by immunohistochemistry as previously described. 16 
Statistical Analysis
Quantitative data are expressed as mean±SEM. Statistical analysis of the data was performed using Prism 6. Student 2-tailed t test was used for 2 experimental group sets, or ANOVA with Tukey multiple comparisons, if data sets included ≥3 groups.
Results

Network Formation by Cooperation Between EC and ASC
We have previously reported 25 that incubation of EC on ASC monolayers in vitro leads to robust EC organization into cord structures ( Figure 1A) . ASC, when cultured in EBM-2/5% FBS in the absence of EC, homogeneously expressed desmin, but expression of αSMA, SM22α, and calponin was undetectable, whereas exposure to EC promptly induced upregulation of all 3 key markers of smooth muscle differentiation in ASC ( Figure 1B ). This differentiation initially occurs concurrently with the tubular morphogenesis of the EC and was dependent on close proximity between EC and ASC. Initial αSMA Nonstandard Abbreviations and Acronyms: expression was first detected in ASC immediately adjacent to EC; it was subsequently noted to extend to ASC positioned more distantly from the EC cords. The nature and rate of EC reorganization into cords were dependent on ASC density ( Figure 1C ): EC cultured on confluent ASC monolayers (60×10 3 ASC/cm 2 ) reorganized into thin cords in 2 to 3 days, whereas EC cultured on nonconfluent ASC monolayers developed into thicker cords (30×10 3 ASC/ cm 2 ) or stayed in clusters (15×10 3 ASC/cm 2 ). Quantitative analysis performed on day 6 revealed that the degree of VNF, represented as the density of total tube length of the network, increases in proportion to the square root of the ASC area density ( Figure 1D ). This observation suggests that contact of EC with ASC is crucial for efficient VNF.
Initial Coalescence Near EC Cords Is Accompanied by αSMA Induction in ASC
To evaluate the temporal relationship between EC morphogenesis into cord structures and induction of αSMA in ASC in more detail, cocultures were fixed at days 2, 4, and 6 after plating and probed with Ulex lectin (EC marker) and αSMA antigen. Analysis of the staining revealed that while well-established cord structures were detected already at day 2 after plating, the upregulation of αSMA expression in ASC surrounding EC-cords was initiated between days 4 and 6 ( Figure 2A ). The process of EC organization into vascular cords was accompanied by a significant increase in ASC accumulation near the cords, as shown using DAPI (4',6-diamidino-2-phenylindole) stain (nuclei stain), suggesting directional ASC migration toward EC cords (Figure 2A , bottom right). This phenomenon was more profound in cultures incubated in EBM-2/1% BSA instead of EBM-2/5% FBS ( Figure 2B ).
Spontaneous Reorganization of SVF Into Vascular Networks
To exclude the possibility that the ability to establish vascular networks was a specific characteristic of in vitro expanded cells, we tested whether freshly isolated adipose tissue-derived Figure 1 . A, Representative phase contrast images of adipose stromal cells (ASC), cord blood-derived endothelial cells (CBD-EC), and EC-ASC cultures at day 6 after plating. B, Representative fluorescent images of ASC and EC-ASC cultures probed for desmin, α-smooth muscle actin (αSMA), SM22, or calponin (red), CD31 (EC marker, green), and nuclei (DAPI [4',6-diamidino-2-phenylindole], blue). C, Representative fluorescent images of EC incubated with different concentrations of ASC for 3 days in endothelial basal media-2/5% FBS, followed by probing for CD31 (green) and nuclei (DAPI, blue). D, Analysis of total tube length density of the networks formed by CBD-EC when incubated with different concentrations of ASC for 6 days (n=6; *P<0.05, ***P<0.001). TTL indicates total tube length. Figure 2 . A, Representative fluorescent images of endothelial cell-adipose stromal cell (EC-ASC) cultures incubated in endothelial basal media (EBM)-2/5% FBS for 2, 4, and 6 days or (B) for 4 days in EBM-2/1% FBS, followed by probing for CD31 (green), αSMA (red), and nuclei (DAPI [4',6-diamidino-2-phenylindole], blue). C, Representative fluorescent images of stromal-vascular fraction (SVF) cultured alone or with cord blood-derived EC (CBD-EC; EC+SVF). Cultures were incubated in EBM-2/1% BSA or EBM-2/5% FBS for 6 days, followed by probing for CD31 (green), α-smooth muscle actin (SMA; red), and nuclei (DAPI, blue). D, Immune blots analyzing expression of αSMA, SM22α, and β-tubulin (protein loading control) in ASC (2 donors) cultivated as monocultures or as cocultures with CBD-EC, human cardiac microvascular EC (HmVEC), human retinal EC (HREC), or saphenous vein EC (SVEC).
SVF, a cell mixture containing 23.3±3.6% of ASC and ≤15% EC (data not shown), was capable of organizing into vascular networks. Because there is no precise way to define the concentration of healthy/functional ASC and EC in the SVF immediately after isolation, SVF was plated at a higher total area density, in comparison with the standard EC-ASC coculture, and was incubated in EBM-2 media with 5% FBS or 1% BSA. The latter conditions were compared to help evaluate the necessity of serum factors for VNF. SVF, when cultivated in either of these media, showed efficient reorganization into vascular networks ( Figure 2C ). These observations suggest that SVF, as a complex composition of several cell types, possesses clear vasculogenic potency in the absence of additional stimuli, such as serum or exogenous growth factors. To determine whether the number of EC was limiting to the vasculogenic activity of ASC within freshly isolated samples, SVF was supplemented with expanded CBD-EC (10 4 cells/cm 2 ). Networks formed by SVF with exogenous EC were denser by comparison with ones formed by SVF alone. Exactly as with cultured ASC, the freshly isolated ASC within SVF increased αSMA expression when in contact with or adjacent to EC ( Figure 2C ).
To demonstrate that ASC differentiation toward SMC, as a result of direct contact with EC, was independent of the source of EC used, ASC were cocultured with EC obtained from cord blood, cardiac microvasculature, saphenous vein, or retina. Expression analysis of such SMC markers as αSMA, calponin, and SM22α at day 6 after incubation by Western blotting has clearly shown that ASC in monocultures had low expression of these antigens, whereas ASC exposed to EC from each source demonstrated substantial induction of their expression ( Figure 2D ). We were unable to detect expression of smooth muscle myosin heavy chain (SM-MHC), the late marker of SMC differentiation, neither in ASC nor in EC-ASC cultures (Online Figure I) . To exclude technical issue, we evaluated lysates prepared from cultured aortic SMC and fresh sample of aorta. SM-MHC was only detected in lysate of aorta but not in cultured SMC. On the basis of this observation, we hypothesize that in vitro expression of SM-MHC is hard to induce in progenitor cells or preserve in differentiated cells. Several studies have shown that laminar flow and pulsatile shear stress deepend the level of cell differentiation and induce expression of SM-MHC. 29, 30 
Effect of Factors Secreted by EC and ASC on ASC Maturation
As we reported previously 25 and shown in Figure 3A , the upregulation of αSMA expression in ASC was only observed in EC-ASC cocultures when ASC had contact with EC. Cultivation of ASC and EC within the same well but physically separated did not induce upregulation of αSMA expression in ASC. Also, no effect was observed when ASCs were exposed to media conditioned for 48 hours by EC or by ASC alone. However, the exposure of ASC to 48-hour EC-ASC CM collected at day 10 after plating showed a profound effect on upregulation of αSMA expression in ASC. Analysis of lysates prepared from ASC samples treated with 48-hour EC-ASC CM collected at days 4 and 10 after plating showed upregulation of αSMA, SM22α, and calponin expression in ASC, as seen in EC-ASC cocultures, whereas cell treatment with ASC CM collected at the same time points had a neutral or inhibitory effect ( Figure 3B ).
Role of TGF β1 and Activin A in αSMA Induction in ASC by EC-ASC CM
Previously it was reported that TGF β1 and activin A can stimulate upregulation of αSMA in several cell types. 31 To confirm it, we exposed ASC to 10 ng/mL of TGF β1 or 25 ng/mL of activin A for 6 days. Staining pretreated ASC revealed upregulation of αSMA expression in both cases ( Figure 4A ). Analysis of cell lysates showed that both factors were able to induce strong expression of all tested markers of smooth muscle differentiation: αSMA, calponin, and SM22α ( Figure 4B ).
To test whether signaling initiated by EC-ASC CM that led to upregulation of αSMA expression in ASC was mediated by TGF β /ALK5 receptor or activin A/ALK4 receptor signaling pathways, we exposed ASC to EC-ASC CM in the presence of an ALK4/5/7 receptor inhibitor. Although EC-ASC CM induced αSMA expression in ASC, the presence of inhibitor in the media completely blocked αSMA expression ( Figure 4C ). To determine which factor was responsible for αSMA upregulation, ASC were exposed to EC-ASC CM pretreated with neutralizing antibodies to TGF β1 or activin A. We found that antiactivin A IgG efficiently blocked induction of αSMA by CM ( Figure 4D ), whereas anti-TGF β1 IgG had no effect. These findings suggest that activin A has a pivotal role in upregulation of αSMA in ASC by EC-ASC CM. Moreover, parallel Western blotting analyses revealed that activin A present in EC-ASC CM was also necessary for inducing expression of calponin and SM22α in ASC ( Figure 4E ). The inhibitory activity of TGF β1 IgG was confirmed by testing its potency to block the effect of 1 ng/mL of TGF β1 on upregulation of αSMA in ASC (data not shown).
Analysis of Activin A, TGF β1 , and Follistatin Expression in ASC and EC-ASC Cultures
Analysis of ASC CM revealed no detectable level of activin A in the media collected at days 3 and 8 after plating. In comparison, activin A was detected in EC-ASC CM collected on both days ( Figure 5A) , with a 17-fold increase in its expression from day 3 to 8. In parallel, TGF β1 was detected in media collected from both types of culture, with a substantial decrement in its concentration as a function of time. The active and total concentrations of TGF β1 were significantly higher in EC-ASC CM for each time point ( Figure 5B ).
Previously it was reported that activin A activity is modulated by a natural inhibitor, specifically follistatin. Analysis of follistatin mRNA levels in ASC and EC-ASC cultures ( Figure 5C ) revealed that its level was similar in both cultures at day 1; cultivating cells for 6 days led to an increase in mRNA level in ASC monoculture by 2.5-fold, whereas in EC-ASC samples it dropped by >50%.
To identify the cell type responsible for the increased activin A in the media, we conducted a coculture/segregation experiment. Cocultures were harvested at day 6 of incubation and separated into individual cell types by flow cytometric sorting based on CD31 (EC) and CD140b (ASC) antigen expression. The segregated EC and ASC were replated for 48 hours for media conditioning. In parallel, EC and ASC, previously maintained in monoculture, were harvested and replated. Analysis of all 4 CM ( Figure 5D ) revealed that although the expression of activin A by EC was unchanged by preincubation with ASC, the level of activin A in CM collected from ASC pre-exposed to EC was >30-fold higher than in the media collected from ASC cultured alone and 5.7-fold higher than detected in EC CM.
Further test revealed a similar increase in activin A accumulation in EC-ASC coculture media when ASC were cultured with either human cardiac microvascular EC or human retinal EC (Online Figure II) .
Dynamics and Cell-Contact Dependence of Activin A Expression in EC-ASC Cultures
To evaluate the dynamics of activin A secretion in EC-ASC cocultures, we performed serial collection of 24-hour CM for 7 days after initial EC-ASC coplating, followed by media evaluation for activin A presence. Based on 2 representative ASC samples, Figure 5E shows that there is a 3-day lag period 
control) or with 10 ng/mL of transforming growth factor-β1 (TGF β1 ) or 25 ng/mL of activin A for 4 days followed by probing for α-smooth muscle actin (SMA; red) and nuclei (DAPI [4',6-diamidino-2-phenylindole], blue). B, Immune blots analyzing expression of αSMA, calponin, SM22, and β-tubulin (protein loading control) in ASC incubated in EBM-2/5% FBS alone or with 10 ng/mL of TGF β or 25 ng/mL of activin A for 6 days. C, Images of ASC cultured in control media or in 48-hour endothelial cell (EC)-ASC conditioned media (CM) alone or supplemented with ALK4/5/7 inhibitor (Inh_II) or dimethyl sulfoxide (DMSO) for 4 days followed by probing for αSMA (red), and nuclei (DAPI, blue). D, Representative images of ASC cultured for 4 days in 48-hour EC-ASC CM alone or supplemented with: antiactivin A IgG; mouse isotype control IgG; anti-TGF β IgG; chicken isotype control IgG. At the end of incubation, cultures were probed for αSMA (red) and nuclei (DAPI, blue). E, Immune blots analyzing expression of desmin, αSMA, calponin, SM22, and GAPDH (protein loading control) in ASC cultured for 6 days in 48-hour intact EC-ASC CM or after media pretreatment with antiactivin A IgG or mouse isotype control IgG.
followed by a dynamic increase in activin A accumulation in CM between days 3 and 6, which reached a plateau by day 6. To evaluate whether this increase in activin A concentration in the media correlated with an increase in CM potency to induce αSMA expression in ASC, 24-hour CM collected from each period (days 1-7) were applied on ASC monolayers for 4 days. Probing ASC cultures for αSMA ( Figure 5F ) revealed that CM collected between days 1 and 4 did not induce αSMA expression in ASC (shown for day 4), whereas media collected on day 5 showed induction potency, which further increased for CM from days 6 and 7. This contrasted with CM from ASC monocultures collected at day 7, which was not able to induce αSMA expression.
To test whether ASC-derived activin A plays an essential role in the activity of EC-ASC media to induce SMC differentiation of ASC further, we performed an experiment to determine whether inhibition of activin A secretion by ASC when in coculture with EC would prevent the induction of αSMA expression in secondary ASC monoculture by EC-ASC CM. ASC were transfected with inhibin B A (monomer of activin A) siRNA or control scRNA before coplating with EC. Fortyeight-hour CM from ASC and EC-ASC cultures collected at day 8 were applied to a reporter ASC monolayer for 5 days. ASC cultured in control media or exposed to ASC CM did not show expression of αSMA, whereas ASC exposed to media collected from EC-ASC control or EC-ASC scRNA demonstrated the expected induction of αSMA ( Figure 6A) . Conversely, the exposure of ASC to EC-ASC siRNA CM was unable to induce αSMA expression in the cell. The siRNA blockade was rescued by media supplementation with 10 ng/mL activin A. Figure 5 . A, Accumulation of activin A in 48-hour conditioned media (CM) from adipose stromal cells (ASC) mono-and endothelial cell (EC)-ASC cocultures, collected at days 3 and 8 after plating (nd: not detected, n=4). B, Dynamics of active and total transforming growth factor-β1 (TGF β1 ) accumulation in 48-hour CM from ASC mono-and EC-ASC cocultures collected at day 3 and 8 after plating (n=4). C, Dynamics of follistatin mRNA expression in ASC and EC-ASC cultures analyzed at days 1 and 6 after plating (n=3). D, Accumulation of activin A in 48-hour media conditioned by ASC and EC. ASC and EC were incubated in control media as monocultures or as EC-ASC coculture for 6 days followed by cell separation by flow cytometry (CD31 for EC, CD140b for ASC) and replating in control media for its conditioning (n=3 for mono-and n=5-6 for cocultures) for 48 hours. E, Dynamics of activin A accumulation in media conditioned by 2 representative EC-ASC cocultures. Each of 2 ASC samples was premixed with 1 sample of cord blood-derived ECs (CBD-EC), plated and incubated in control media with daily media harvest (24-hour CM) and exchange during first 7 days of incubation. F, Representative images of ASC incubated for 4 days in control media, in 24-hour ASC CM collected at day 7 or in 24-hour EC-ASC CM collected at days 4 to 7, followed by probing for α-smooth muscle actin (SMA) (red) and nuclei (DAPI [4',6-diamidino-2-phenylindole], blue). EC-ASC coculture was used as a positive control for induction of αSMA expression in ASC (*P≤0.05, **P≤0.01, ***P≤0.001). October 10, 2014
To evaluate whether TGF β could be responsible for induction of activin A expression by ASC in the context of EC-ASC, ASCs were exposed to 0.5 ng/mL of TGF β1 in EBM-2/5% FBS media for 24 hours. Such treatment caused accumulation of activin A in the incubation media ( Figure 6B ). However, incubation of EC-ASC cocultures in the presence of a neutralizing IgG specific to TGF β1 or a pan-TGF β IgG with a broader neutralizing activity (TGF β1 , TGF β2 , and TGF β3 ) did not reduce the accumulation of activin A in the media ( Figure 6C) . Similarly, supplementing EC-ASC cocultures incubation media with SB431542, small molecular inhibitor of the TGF β receptor, did not reduce activin A accumulation in CM ( Figure 6D ). The potency of TGF β IgGs and SB431542 to efficiently block TGF β1 activity, causing induction of activin A expression in ASC, was confirmed (Online Figure III) . To test the importance of direct heterotypic cell-cell contact for activin A induction in ASC, ASC and EC were cocultured on Transwell inserts after seeding either on the same or opposite sides of a 10-µm-thick mesh with 0.4-µm pore size. In the latter case, close proximity of the cells to each other was established without direct cell contact. A substantial accumulation of activin A was observed in the media collected from cells incubated in direct contact but not in media from coculture when EC and ASC were separated by the membrane or from ASC monoculture ( Figure 6E ). The fact that activin A level in contact cultures was 38-and 16-fold higher than in ASC monocultures and cocultures without contact, respectively, provides clear evidence that direct heterotypical cell contact is a key triggering mechanism in induction of activin A expression in ASC.
To test whether the time-dependent increase in activin A production by EC-ASC cocultures identified in vitro is also present in in vivo, EC and ASC, mixed in 1:1 ratio, were resuspended in Matrigel and injected subcutaneously into NOD/ SCID/IL2Rγ mice. Staining thin sections of implants harvested at day 7 with antihuman CD31 antibodies revealed efficient development of the human origin vessels. The presence of blood cells in the vessel lumens suggests neo-vessel integration with the host vasculature ( Figure 6F ). Analysis of inhibin B A mRNA expression in the plugs ( Figure 6G ) harvested at days 1 and 7 revealed a progressive increase in inhibin B A expression by >3-fold.
Partial Role of Activin A and ALK4/5/7 in αSMA Induction in EC-ASC Cocultures
Although activin A IgG was able to block the effect of EC-ASC CM on upregulation of αSMA in ASC completely ( Figure 4D) , the presence of antibodies in the EC-ASC coculture only partially blocked αSMA expression in ASC ( Figure 7A ). Specifically, the inhibition of αSMA expression was restricted to ASC that were remote from EC cords and not in direct contact with EC, whereas the expression of αSMA remained strong in ASC adjacent to EC cords. Similarly, when ALK4/5/7 inhibitor (Inh_II) was added to the EC-ASC coculture, a decrease in αSMA expression was exclusively detected in ASC distant from EC cords ( Figure 7A ).
Evaluation of SMAD2 Phosphorylation in ASC and EC-ASC Cultures
When cultured in EBM-2/5% FBS, ASC express a basal level of phosphorylated SMAD2 (pSMAD2) (downstream mediator of activin A and TGF β1-3 signaling). The exposure of ASC to ASC CM collected at day 8 decreased the pSMAD2 level, whereas ASC treatment with EC-ASC CM induced a significant increase in the pSMAD2 level ( Figure 7B ). This effect was completely blocked by an ALK4/5/7 inhibitor but not by the control carrier dimethyl sulfoxide. A similar activation effect was observed when ASC were directly cocultured with EC ( Figure 7C ). When cocultures were incubated in the presence of ALK4/5/7 inhibitor, SMAD2 phosphorylation was returned to control level.
Discussion
This is the first study to use a fully human EC/mesenchymal cell coculture model to demonstrate the role of activin A in guiding mesenchymal stem/stromal cells toward a more mature phenotype, which is essential to fulfill ASC vesselstabilizing activity. Although several previous studies have identified a role for TGFβ 1 in similar processes in nonhuman primary cell types or immortalized cell lines and cross-species coculture models, 41, 45 our study has established that activin A (and not TGFβ) plays a unique role in the heterotypic interaction of human EC and mural cells.
In our previous work, we have shown that ASC in an in vivo setting readily interact with EC, leading to formation of stable multilayered vessels. 9 Understanding the key factors that are involved in EC-ASC interaction and the sequence of events mediating EC and ASC assembly into mature functional vessels is important in the development of vascular therapies and fabrication of vascularized tissues. The present study addressed one specific aspect of heterocellular vascular assembly: namely, a series of events by which ASC acquire properties of mural/SMC.
Using an in vitro model of EC-ASC cocultivation, we attempted to recreate and dissect sequential events observed in in vivo cell cotransplantation experiments. As EC organize into vessel-like cords during the first 3 days of incubation, ASC migrate and accumulate around the nascent EC cords, and differentiate from a progenitor phenotype toward a smooth muscle lineage. This phenotypic change demonstrated regional upregulation of αSMA, SM22α, and calponin expression in a spatial context suggestive of a periendothelial niche ( Figure 1B) . These phenomena were observed in cultures comprised of expanded EC and ASC, which potentially have acquired new properties during in vitro cultivation as well as in cultures composed exclusively of freshly isolated SVF of adipose tissue. This suggests that SVF may be an attractive cell composition for stimulation of local vasculogenesis.
The finding that EC organization into cords precedes ASC acquisition of mural cell properties as denoted by emerging expression of αSMA (Figure 2A ) suggests that these processes are orchestrated and sequential. In particular, direct contact of ASC with EC strongly induced upregulation of SMC antigen expression and activin A secretion in ASC after 3 to 4 days of cocultivation ( Figure 5E ).
Our previous study 21 showed that an early event in EC-ASC interaction is the chemotaxis of ASC toward nascent vascular cords in response to EC-released factors (Figure 2A and 2B) . Similarly, it has been shown that PDGF-BB, secreted by EC, was responsible for 10T1/2 cell directional migration in a semisolid underagarose coculture model, 32 whereas blocking PDGF-BB signaling prevents accumulation of αSMA+ASC around EC cords 26 in a model similar to ours. It is not clear how a physiologically meaningful gradient of chemoattractants might be established in 2-dimensional culture models. We hypothesize that the extracellular matrix formed by EC and ASC activities plays an essential role in supporting directional cell migration. Notably, the development of vascular networks in serum-free media suggests that EC tubulogenesis is not dependent on components of bovine serum ( Figure 2B ). In fact, ASC incubated in media containing 1% BSA manifested more dramatic migration toward EC cords when compared with ASC cultured in the presence of 5% FBS, suggesting that some factors in FBS are masking EC cues that contribute to ASC directional migration. October 10, 2014
The factors responsible for the initial induction of activin A expression in ASC adjacent to EC cords have yet to be identified. The fact that 48-hour EC-ASC CM, collected at day 8, was unable to induce activin A expression in ASC suggests that the factor responsible for activin A induction is not significantly present in the EC-ASC CM. Previously, it has been shown that TGF β induces activin A expression in several cell types, 31, 33 and we have confirmed this finding for ASC ( Figure 6B ). However, additional experiments revealed that targeted blocking of the TGF β signaling pathway in EC-ASC cocultures at the level of either ligand or receptor did not affect activin A accumulation in the media, suggesting another mechanism responsible for activin A induction ( Figure 6C and 6D) .
We hypothesize that the expression of activin A would be exclusively induced in ASC that are adjacent to EC cords. We supported it by demonstrating that coincubation of EC with ASC while separated by a 10-µm-thick mesh with 0.4-µm pores prevented activin A accumulation in CM ( Figure 6E ). Such a mesh prohibits direct heterocellular contact but places the cells in direct proximity with free exchange of bioactive molecules, while minimizing dilution effect by the bulk media. Additional studies will be required to identify the mechanisms of activin A induction in ASC.
Although the current study corroborates previous findings that TGF β1 , is secreted by EC, 34 and is able to induce αSMA expression in ASC 11, 35 (Figure 4A, B) , it was not essential for the induction of αSMA expression in ASC in the model used. Rather, we demonstrated, for the first time, that activin A mediates the SMC differentiation program in ASC. However, the fact that ALK4/5/7 inhibition was shown to block phosphorylation of SMAD2 completely (a downstream factor necessary for both TGF β and activin A signaling) but was not able to block expression of αSMA in ASC fully that were adjacent to EC-cords suggests that neither TGF β nor activin A was the initiating factors through which EC signal ASC to begin differentiation along a SMC pathway. This contrasts with studies that demonstrated an increase in activated TGF β production as a result of bovine aortic or retinal EC cultivation with either bovine retinal pericytes or aortic SMC or with mouse C3H/10T1/2 cell line. These studies suggested an essential role of TGF β in differentiation of these cells into SMC. 32, 36 However, the current study revealed a decrease in total and active TGF β1 forms as a function of cultivation time. Further evidence against a critical role for TGF β in this human primary cell system is presented by the finding that pretreatment of EC-ASC CM with TGF β IgG did not diminish the CM potency to upregulate αSMA expression in ASC ( Figure 4D ).
Previous studies have noted a significant role of activin A in endothelial tubulogenesis on a collagen matrix. 37 This finding is complemented by our discovery that activin A plays a role in directing smooth muscle differentiation in ASC. Another study has shown that activin A has mitogenic effects on human adipose progenitors and inhibits differentiation along an adipogenic lineage. 38 Although we did not identify significant mitogenic effects of activin A on ASC (data not shown), these findings suggest that activin A plays an important role in promoting a vascular rather than adipogenic lineage fate for ASC, in the region of an endothelial niche.
Our initial in vitro finding showing that the interaction between EC and ASC promotes activin A expression was supported by our observation that subcutaneous implantation of EC/ASC mixture in a gel matrix leads to an increase in inhibin B A expression by the cells as a function of incubation time ( Figure 6G) .
Additional in vivo studies will be necessary to determine the extent to which cotransplantation of EC with ASC may modulate the fate of transplanted ASC. Such effects have relevance to clinical applications, which may depend on different in vivo ASC behaviors. While in reconstructive therapies, an adipogenic ASC fate may facilitate tissue volume expansion, 39 the ability of ASC to promote vascularization concurrent with their smooth muscle-directed differentiation is likely to be desirable in vascular applications. On the basis of this study, we speculate that modulation of activin A signaling may play a useful role in directing the fate of ASC for therapeutic benefit. 
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